Evidence map›Paper›PMID 39808329›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Adverse health outcomes and health-related quality of life (HRQoL) among long-term adolescent and young adult (AYA) brain tumour survivors: results from the population-based SURVAYA study.

Konstantinos Angoumis, Catarina S Padilla, Mathilde C M Kouwenhoven, Rhodé M Bijlsma, Suzanne E J Kaal, Jacqueline M Tromp, Monique E M M Bos, Tom van der Hulle, Martinus P G Broen, Janine Nuver and 3 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  4. Article
  5. Review
  6. Central Nervous System Tumors in Adolescents and Young Adults.Current neurology and neuroscience reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Konstantinos AngoumisUniversity of Bielefeld, School of Public Health, 33615, Bielefeld, Germany.ORCID http://orcid.org/0009-0003-9663-6643
Catarina S PadillaDepartment of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands. c.simoespadilla@erasmusmc.nl.ORCID http://orcid.org/0000-0003-1821-3760
Mathilde C M KouwenhovenDepartment of Neurology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam University Medical Centers, Location VUmc, 1081 HV, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-5252-4365
Rhodé M BijlsmaDepartment of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0003-0980-6652
Suzanne E J KaalDepartment of Medical Oncology, Radboud University Medical Center, 6525 GA, Nijmegen, the Netherlands.ORCID http://orcid.org/0000-0002-8063-0074
Jacqueline M TrompDepartment of Medical Oncology, Amsterdam University Medical Centers, 1105 AZ, Amsterdam, the Netherlands.
Monique E M M BosDepartment of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0002-9415-6342
Tom van der HulleDepartment of Medical Oncology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.ORCID http://orcid.org/0000-0002-2296-1828
Martinus P G BroenDepartment of Neurology, GROW‑School of Oncology and Reproduction, Maastricht University Medical Center+, 6229 HX, Maastricht, the Netherlands.ORCID http://orcid.org/0000-0002-8834-2202
Janine NuverDepartment of Medical Oncology, University Medical Center Groningen, 9713 GZ, Groningen, the Netherlands.ORCID http://orcid.org/0000-0001-7966-5301
Winette T A van der GraafDepartment of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0001-7549-3338
Sophie PaugeSchool of Public Health, Department of Health Economics and Healthcare Management, University of Bielefeld, 33615, Bielefeld, Germany.ORCID http://orcid.org/0000-0002-6032-0239
Olga HussonDepartment of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, 1066 CX, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-1387-8686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdolescent and young adult (AYA) malignant brain tumour (BT) survivors are at risk of adverse health outcomes, which may impact their health-related quality of life (HRQoL). This study aimed to investigate the (1) prevalence of physical and psychological adverse health outcomes, (2) the HRQoL, and (3) the association of adverse health outcomes and HRQoL among long-term AYA-BT survivors. Adverse health outcomes and HRQoL were compared to other AYA cancer (AYAC) survivors.

methodsA cross-sectional secondary data analysis of the SURVAYA study among 133 AYA-BT and 3877 AYAC survivors was conducted. Participant self-reported adverse health outcomes and HRQoL scores were analysed and compared between the two populations. Associations with HRQoL were assessed using linear regression modelling with AIC-based backward elimination.

resultsAYA-BT survivors faced significant issues of fatigue (47.6%), future uncertainty (45.2%), and medical conditions like vision (34.4%), speech, taste, or smell (26.2%) impairments, cancer recurrence, and metastasis (25.4%). Neurocognitive symptoms were identified as BT-specific issues (13.6-33.6%). Compared to AYAC survivors, AYA-BT survivors reported significantly (p < 0.05) lower functioning scores on the role, cognitive, emotional, and social HRQoL, with cognitive (56.0%) and emotional (40.0%) domains being the most affected. Adverse health outcomes were negatively associated with HRQoL, ranging from small to large clinical relevance.

conclusionLong-term AYA-BT survivors were identified as a highly burdened population, affected by multifaceted issues and multidimensional detriments in HRQoL years beyond their cancer diagnosis. This study highlights the necessity of long-term follow-up and a holistic, multidisciplinary approach to survivorship care to ultimately improve the quality of AYA-BT survivorship.

Indexed as

Brain NeoplasmsCancer SurvivorsQuality of LifeAdolescentAdultCross-Sectional StudiesFemaleHealth StatusHumansMaleYoung AdultAdverse health outcomesHealth-related quality of lifeLate effectsNeurooncologySurvivorship

Identifiers

PMID39808329
PMCPMC11732903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.